本文關(guān)鍵詞：我國(guó)當(dāng)前藥品短缺的經(jīng)濟(jì)學(xué)分析　出處：《現(xiàn)代經(jīng)濟(jì)探討》2017年10期 　論文類型：期刊論文

  更多相關(guān)文章： 藥品短缺 醫(yī)療改革 低價(jià)藥 罕見病藥

【摘要】：藥品短缺現(xiàn)象及其直接原因,可以從非均衡理論、壟斷理論與制度經(jīng)濟(jì)學(xué)角度進(jìn)行分析,價(jià)格管制、地方招標(biāo)采購、新藥審批等制度中的設(shè)計(jì)缺陷是造成我國(guó)藥品短缺的主要原因。解決當(dāng)前藥品短缺問題的重點(diǎn)在于恢復(fù)藥品市場(chǎng)定價(jià)機(jī)制,構(gòu)建更具競(jìng)爭(zhēng)性的招標(biāo)采購機(jī)制,建立招標(biāo)市場(chǎng)以外的藥品自由流通市場(chǎng),降低市場(chǎng)壁壘,防止市場(chǎng)準(zhǔn)入管制與招標(biāo)機(jī)制成為分割藥品市場(chǎng)和保護(hù)本地企業(yè)的手段,同時(shí)加強(qiáng)政府履行維護(hù)市場(chǎng)有效競(jìng)爭(zhēng)的職責(zé),并為特殊性、公益性藥品提供最后的供應(yīng)保障。
[Abstract]:The phenomenon of drug shortage and its direct causes can be analyzed from the angle of non-equilibrium theory, monopoly theory and institutional economics, price control, local bidding and procurement. The design defects in the new drug examination and approval system are the main causes of drug shortage in China. The key to solve the current drug shortage problem lies in the restoration of drug market pricing mechanism and the construction of a more competitive bidding procurement mechanism. Establish the free circulation market of drugs outside the bidding market, reduce the market barriers and prevent the market access control and bidding mechanism from becoming the means to separate the drug market and protect the local enterprises. At the same time, strengthen the government's duty to maintain effective competition in the market, and provide the final supply guarantee for particularity and public welfare drugs.
【作者單位】： 中國(guó)社會(huì)科學(xué)院研究生院工業(yè)經(jīng)濟(jì)系;中國(guó)社會(huì)科學(xué)院工業(yè)經(jīng)濟(jì)研究所;
【分類號(hào)】：F426.72
【正文快照】： 品出現(xiàn)短缺。由此可見,藥品短缺問題并沒有得到一、問題的提出根本解決,“一藥難求”的現(xiàn)象甚至使十幾元、幾十元2009年新一輪醫(yī)改以來,我國(guó)堅(jiān)持立足國(guó)情、公的藥品炒到上千元,增加了患者醫(yī)療負(fù)擔(dān),提高了醫(yī)平與效率統(tǒng)一、市場(chǎng)與政府結(jié)合和統(tǒng)籌兼顧的原則,療機(jī)構(gòu)的費(fèi)用成本,也，

本文編號(hào)：1377237